Dxterity Diagnostics Inc.

DxTerity was founded in 2006 with the mission of enabling “Genomics in Everyday Care”. Genomic testing is a key enabler of Precision Medicine, providing a finer level of disease stratification than is possible using traditional medical testing. DxTerity specializes in all aspects of genomic test development including gene signatures optimization, Quality System Regulation (QSR) compliant product development, transfer to manufacturing, test validation, and cGMP manufacturing. Of particular interest for many test developers is our Direct-to-Patient (D2P) clinical research platform that uses digital recruitment, consenting, and monitoring of clinical study participants. D2P is frequently combined with our DxCollect Fingerstick Collection Kit to obtain blood samples for the development and validation of genomic tests. D2P expands clinical studies to include Anyone, Anytime, Anywhere, and can dramatically lower the cost and speed the process of validating a promising genomic test. In addition to providing contract